Quantcast
Last updated on April 20, 2014 at 19:30 EDT

Latest Viral hepatitis Stories

2013-04-08 08:30:51

RIDGEFIELD, Conn., April 8, 2013 /PRNewswire/ -- Boehringer Ingelheim today announced that data from its pivotal STARTVerso(TM) 1 Phase 3 hepatitis C clinical trial have been accepted for oral presentation as a late-breaker at the International Liver Congress(TM) 2013: 48th Annual Meeting of the European Association for the Study of the Liver (EASL), taking place from April 24-28 in Amsterdam, The Netherlands. The STARTVerso(TM) 1 trial evaluated faldaprevir (BI 201335), an investigational...

2013-03-28 16:25:12

-- Filing Based on Phase 3 Data in Treatment-Naïve and Treatment-Experienced Patients with Compensated Liver Disease -- RARITAN, N.J., March 28, 2013 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) today announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for simeprevir (TMC435), an investigational NS3/4A protease inhibitor, administered as a 150 mg capsule once daily with...

2013-02-20 12:44:46

A study reveals how daclatasvir targets one of its proteins and causes the fastest viral decline ever seen with anti-HCV drugs — within 12 hours of treatment. A study by researchers from Los Alamos National Laboratory and a multinational team reveals how daclatasvir, a direct-acting antiviral agent in development for the treatment of hepatitis C virus (HCV), targets one of its proteins and causes the fastest viral decline ever seen with anti-HCV drugs — within 12 hours of...

2013-02-19 20:22:01

LOS ALAMOS, N.M., Feb. 19, 2013 /PRNewswire-USNewswire/ -- A study by researchers from Los Alamos National Laboratory and a multinational team reveals how daclatasvir, a direct-acting antiviral agent in development for the treatment of hepatitis C virus (HCV), targets one of its proteins and causes the fastest viral decline ever seen with anti-HCV drugs - within 12 hours of treatment. Chronic infection with hepatitis C virus affects about 150 million people worldwide. It is the leading cause...

2013-02-01 09:53:36

Each intravenous drug user contracting Hepatitis C is likely to infect around 20 other people with the virus, half of these transmissions occurring in the first two years after the user is first infected, a new study estimates. The work, led by researchers from Oxford University, suggests that early diagnosis and treatment of Hepatitis C in intravenous drug users could prevent many transmissions by limiting the impact of these 'super-spreaders' (a highly infectious person who spreads a...

2013-01-24 23:00:10

The Association of Asian Pacific Community Health Organizations (AAPCHO) received a 3-year grant totaling over $700,000 from the National Institutes of Health (NIH) to develop new Health Information Technology strategies that increase screening for chronic hepatitis B and reduce the impact of hepatitis B among high-risk Asian American and Pacific Islander populations. First study to evaluate health information technology strategies for low-income Asian American and Pacific Islander...

2013-01-11 05:03:06

Hepatitiscnews.com will provide practical advice and support to people living with hepatitis C (PRWEB) January 10, 2013 A new website, aimed at providing practical advice and support to people living with hepatitis C, has been launched. The new site - http://www.hepatitiscnews.com - has been developed to deliver accessible information on hepatitis C, an infectious liver disease that affects around 150 million people worldwide. Hepatitiscnews.com features tips on living well with hepatitis...

2012-12-13 12:25:24

RESTON, Va., Dec. 13, 2012 /PRNewswire-USNewswire/ -- Clinical Care Options (CCO), a global leader in education for healthcare professionals, announced its partnership with the Australasian Society for HIV Medicine (ASHM). With more than 1000 members, ASHM is the leading Australasian organization representing the medical and health sector in HIV, viral hepatitis, and related areas and mandated by the Australian government to certify primary care clinicians for competency as prescribers of...

2012-12-09 05:02:15

ReportsnReports.com adds new market research report “France Blood Banking Market: Innovative Technologies and Emerging Business Opportunities” to its store. Dallas, Texas (PRWEB) December 09, 2012 These reports provide comprehensive analysis of the French and Germany blood banking market, including: Major issues pertaining to the French and Germany blood banking practice, as well as key economic, regulatory, demographic, social and technological trends with significant market...

2012-11-27 12:29:02

Summit on HIV and Viral Hepatitis Charts Priorities to Accelerate Testing, Reduce Disparities in Care WASHINGTON, Nov. 27, 2012 /PRNewswire-USNewswire/ -- As the countdown to implementation of the Affordable Care Act begins in earnest, experts on the front lines in fighting viral hepatitis and HIV/AIDS issued this harsh assessment regarding escalating levels of hepatitis C virus (HCV) infection: unless policymakers require insurers to cover the costs of screening everyone at potential...


Latest Viral hepatitis Reference Libraries

Hepatitis B
2013-02-25 09:11:23

Image Caption: This electron micrograph reveals the presence of hepatitis-B virus HBV "Dane particles", or virions. Credit: CDC/Wikipedia Hepatitis B: What Is It? Hepatitis simply means a swelling or inflammation of the liver. The type hepatitis that a person contracts (there are 5 common forms) affects their long-term prognosis. The most common and most severe of these different types of liver infection is Hepatitis B, which is caused by the hepatitis B virus (HBV). It is typically...

69_3e2a06a821d939ffdc2eab851bee21e9
2011-01-24 12:50:52

Hepatitis A, caused by hepatitis A virus, is an acute infectious disease of the liver that is transmitted person to person by ingestion of contaminated food or water or through direct contact with an infectious person. Millions of people are believed to become infected with HAV every year. The incubation period is two to six weeks and on average is 28 days. In less developed countries the HAV is usually contracted in early childhood. Clean water helps to decrease contraction of HAV. In 90%...

11_9e88d15808b8ecc3fcbbdfcf4ae75786
2011-01-20 19:23:30

Hepatitis C virus (HCV) is an enveloped, positive-sense single-stranded RNA virus of the family Flaviviridae. It consists of a core of genetic material surrounded by an icosahedra protective shell of protein. The genome consists of a single open reading frame that is 9600 nucleotide bases long. HCV replication takes several steps. It primarily replicates in the hepatocytes of the liver. It can also reproduce in peripheral blood mononuclear cells. There is a wide variety of genotypes and...

45_36624a455e3cd9a4152b7670308f0ffa
2011-01-20 19:14:56

Hepatitis B virus, HBV, is a part of the Hepadnaviridae family of viruses. HBV can lead to cirrhosis and hepatocellular carcinoma and has been linked to pancreatic cancer. It is classified as a species of the Orthohepadnavirus. Similar viruses have been found worldwide in great apes and monkeys. There a few different genotypes and they all differ by at least 8% of the sequence and have distinct geographical distributions and this has been associated with anthropological history. Type A is...

0_9255b919f71eff1fd4202c1dbb1795d2
2011-01-12 15:49:29

Hepadnaviruses can cause liver infections in humans and animals. The two recognized genera are Genus Orthohepadnavirus and Genus Avihepadnavirus. It has a small genome of partially double-stranded, partially single stranded circular DNA. It is a group 7 virus that uses an RNA intermediate during replication. Most people who come into contact with the virus are able to clear the infection alone although some cannot and usually progress to fulminant hepatitis. It can cause sever liver...

More Articles (5 articles) »